EGFR ligand shifts the role of EGFR from oncogene to tumor suppressor in EGFR amplified glioblastoma by suppressing invasion through BIN3 upregulation
Ontology highlight
ABSTRACT: For LUM2_529995_Vehicle_24 and LUM2_529996_EGF_24, GBM12 cells were treated with vehicle or EGF for 24 hours, cells lysates were immunoprecipitated by BIN3 antibody and subjected to Mass spectrometry (MS) analysis.
For LUM2_626031_Vehicle_0pt5 and LUM2_626032_EGF_0pt5, GBM12 cells were treated with vehicle or EGF for 30 minutes, cells lysates were immunoprecipitated by EGFR antibody and subjected to Mass spectrometry (MS) analysis.
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)
SUBMITTER: Amyn A. Habib
PROVIDER: MSV000089272 | MassIVE | Mon Apr 18 13:10:00 BST 2022
REPOSITORIES: MassIVE
ACCESS DATA